INVIVOSCRIBE INC.

In News

Newmark Arranges Lease Renewal for Invivoscribe’s U.S. Headquarters in San Diego’s Sorrento Mesa Submarket - Newmark

Newmark - Oct 09, 2025

Invivoscribe Expands Flow Cytometry Services to Accelerate CAR-T Immunotherapy Development and Regulatory Readiness with the Initiation of CERo Therapeutics Phase 1 Clinical Trial - Business Wire

Business Wire - Jul 08, 2025

Invivoscribe’s LabPMM Gains New York State Approval for the FLT3 ITD MRD Assay - Business Wire

Business Wire - Apr 22, 2025

Hitachi High-Tech and Invivoscribe partner to advance molecular diagnostics and precision medicine - PR Newswire

PR Newswire - May 09, 2022

Precision Diagnostics & Medicine Market Current Scenario Analysis Report - Insightace Analytic

Insightace Analytic - Dec 23, 2025

Measurable residual mutated NPM1 before allogeneic transplant for acute myeloid leukemia - Nature

Nature - Nov 24, 2025

Kronos Bio and Invivoscribe Partner on Companion Diagnostic for Use with Entospletinib, Kronos Bio's Investigational Compound Being Developed for Patients with AML - PR Newswire

PR Newswire - Aug 16, 2022

Global Companion Diagnostics Market to Register Immense Growth at a CAGR of ~12% by 2032 | DelveInsight - The Malaysian Reserve

The Malaysian Reserve - Mar 06, 2026

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment